Kanya Rajangam - Pres. & Chief Med. & Dev. Off. at Senti Biosciences, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Pres. & Chief Med. & Dev. Off.
Stock Symbol
SNTI on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Kanya Rajangam since 12/22/2023

Holdings reported by Kanya Rajangam for Senti Biosciences, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Series A Convertible Preferred Stock 33 $74.3K $2,250.00 Dec 9, 2024 Iyer Family Revocable Trust dated Aug 26 2012 Common Stock
Stock Option (Right to Buy) 152K Feb 1, 2024 Direct Common Stock
Common Stock 101K Feb 1, 2024 Direct
Common Stock Warrant (right to buy) 49.5K Dec 9, 2024 Iyer Family Revocable Trust dated Aug 26 2012 Common Stock

Transactions reported by Kanya Rajangam for Senti Biosciences, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.